NM_014625.4:c.686G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2

The NM_014625.4(NPHS2):​c.686G>A​(p.Arg229Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0348 in 1,613,872 control chromosomes in the GnomAD database, including 1,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R229R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.028 ( 85 hom., cov: 32)
Exomes 𝑓: 0.036 ( 1056 hom. )

Consequence

NPHS2
NM_014625.4 missense

Scores

1
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:13U:11B:2O:2

Conservation

PhyloP100: 2.46

Publications

179 publications found
Variant links:
Genes affected
NPHS2 (HGNC:13394): (NPHS2 stomatin family member, podocin) This gene encodes a protein that plays a role in the regulation of glomerular permeability. Mutations in this gene cause steroid-resistant nephrotic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
NPHS2 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, type 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, G2P
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 29 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Gene score misZ: 0.68612 (below the threshold of 3.09). Trascript score misZ: 0.038296 (below the threshold of 3.09). GenCC associations: The gene is linked to nephrotic syndrome, type 2, familial idiopathic steroid-resistant nephrotic syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.00867492).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0277 (4222/152288) while in subpopulation NFE AF = 0.0374 (2543/68022). AF 95% confidence interval is 0.0362. There are 85 homozygotes in GnomAd4. There are 2112 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 85 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014625.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS2
NM_014625.4
MANE Select
c.686G>Ap.Arg229Gln
missense
Exon 5 of 8NP_055440.1
NPHS2
NM_001297575.2
c.535-2548G>A
intron
N/ANP_001284504.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS2
ENST00000367615.9
TSL:1 MANE Select
c.686G>Ap.Arg229Gln
missense
Exon 5 of 8ENSP00000356587.4
NPHS2
ENST00000367616.4
TSL:1
c.535-2548G>A
intron
N/AENSP00000356588.4
NPHS2
ENST00000902256.1
c.509G>Ap.Arg170Gln
missense
Exon 3 of 6ENSP00000572315.1

Frequencies

GnomAD3 genomes
AF:
0.0277
AC:
4222
AN:
152170
Hom.:
85
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00611
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.0187
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.0281
Gnomad FIN
AF:
0.0664
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0374
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.0304
AC:
7639
AN:
250894
AF XY:
0.0313
show subpopulations
Gnomad AFR exome
AF:
0.00621
Gnomad AMR exome
AF:
0.0128
Gnomad ASJ exome
AF:
0.0524
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0697
Gnomad NFE exome
AF:
0.0358
Gnomad OTH exome
AF:
0.0295
GnomAD4 exome
AF:
0.0355
AC:
51908
AN:
1461584
Hom.:
1056
Cov.:
32
AF XY:
0.0356
AC XY:
25877
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.00574
AC:
192
AN:
33478
American (AMR)
AF:
0.0140
AC:
626
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0485
AC:
1267
AN:
26132
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39686
South Asian (SAS)
AF:
0.0280
AC:
2415
AN:
86242
European-Finnish (FIN)
AF:
0.0661
AC:
3527
AN:
53374
Middle Eastern (MID)
AF:
0.0170
AC:
98
AN:
5764
European-Non Finnish (NFE)
AF:
0.0376
AC:
41780
AN:
1111840
Other (OTH)
AF:
0.0331
AC:
2000
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2523
5046
7569
10092
12615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1574
3148
4722
6296
7870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0277
AC:
4222
AN:
152288
Hom.:
85
Cov.:
32
AF XY:
0.0284
AC XY:
2112
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00609
AC:
253
AN:
41556
American (AMR)
AF:
0.0186
AC:
285
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3468
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5192
South Asian (SAS)
AF:
0.0282
AC:
136
AN:
4830
European-Finnish (FIN)
AF:
0.0664
AC:
704
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0374
AC:
2543
AN:
68022
Other (OTH)
AF:
0.0199
AC:
42
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
210
420
631
841
1051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0316
Hom.:
224
Bravo
AF:
0.0232
TwinsUK
AF:
0.0394
AC:
146
ALSPAC
AF:
0.0394
AC:
152
ESP6500AA
AF:
0.00772
AC:
34
ESP6500EA
AF:
0.0376
AC:
323
ExAC
AF:
0.0291
AC:
3537
Asia WGS
AF:
0.00722
AC:
26
AN:
3478
EpiCase
AF:
0.0356
EpiControl
AF:
0.0352

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
9
6
-
Nephrotic syndrome, type 2 (15)
2
3
-
not provided (5)
-
1
1
not specified (2)
-
-
1
Focal segmental glomerulosclerosis (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
NPHS2-related disorder (1)
-
1
-
Proteinuria (1)
-
-
-
Nephrotic syndrome (1)
-
-
-
NEPHROTIC SYNDROME, TYPE 2, SUSCEPTIBILITY TO (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.040
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.71
D
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0087
T
MetaSVM
Uncertain
0.010
D
MutationAssessor
Benign
1.7
L
PhyloP100
2.5
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.58
Sift
Benign
0.21
T
Sift4G
Benign
0.18
T
Polyphen
0.90
P
Vest4
0.11
MPC
0.81
ClinPred
0.030
T
GERP RS
5.9
Varity_R
0.42
gMVP
0.66
Mutation Taster
=59/41
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61747728; hg19: chr1-179526214; COSMIC: COSV62635238; COSMIC: COSV62635238; API